Abridge Raises $30M to Accelerate Adoption of its Proven Generative AI Solution Across U.S. Healthcare Systems

Abridge, the leader in generative AI for clinical documentation, announced a Series B raise of $30 million, led by Spark Capital. The round also included existing investor Bessemer Venture Partners, as well as several leading healthcare innovators including CVS Health Ventures, Kaiser Permanente Ventures, Lifepoint Health, Mayo Clinic, SCAN Group, UC Investments (University of California), and the American College of Cardiology. This investment will support large-scale health system rollouts and accelerate product advances that will create additional value for patients, clinicians, and health systems. “Spark Capital is proud to lead this industry-defining investment in Abridge,” said Will Reed, a General Partner at Spark Capital focused on growth-stage AI investments. “We chose to invest in Abridge based on their deep AI-native talent led by Zack Lipton, Chief Scientific Officer, their commitment to building solutions around deep clinical workflows, and the overwhelming positivity from customers.” Abridge’s software automatically converts a patient-clinician conversation into a structured clinical note draft in real time, leveraging their proprietary AI pipeline. The solution has been proven to save clinicians over two hours per day from administrative burdens that previously took time away from patients and detracted from clinician work-life balance. In recent implementations, over 91% of notes across over 40 specialties were drafted solely with their AI, requir...
Source: EMR and HIPAA - Category: Information Technology Authors: Tags: Health IT Company Healthcare IT Abridge American College of Cardiology Bessemer Venture Partners CVS Health Ventures Dr. John D. Halamka Dr. Shiv Rao Emory Healthcare Epic Health IT Funding Health IT Fundings Health IT Investment Source Type: blogs